Characterization, bioactivity investigation and cytotoxicity of borosilicate glass/dicalcium silicate composites
Source abstract
Abstract
Abstract Composites of dicalcium silicate cement (C2S), prepared by solid state reaction, were fabricated with 5, 10, 15 and 20 wt% additions of borosilicate glass (BG) prepared by melt–quenching method. Bioactivity behavior of the cement and its composites was estimated by soaking in simulated body fluid (SBF) at 37 ± 0.5 °C for 28 days. Physico-mechanical properties of the cement and its composites were measured. The variations of pH, Ca and P ions concentrations in the SBF solution after soaking were determined. Additionally, the structure was analyzed using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) coupled with energy dispersive spectroscopy (EDS). Evaluation of the cytotoxicity against human normal fibroplast cell line (BJ1) was also carried out. Results showed the formation of hydroxyapatite (HA) layer on the surface of investigated materials after immersion in SBF solution. It can be pointed out that increasing BG content in the present cement composition enhances the mechanical properties and the bioactivity behavior of the cement. Moreover, with increasing the content of BG in cement, the cytotoxicity effect decreases, making these materials possible candidates for dental applications.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. Bonding mechanisms at the interface of ceramic prosthetic materials10.1002/jbm.820050611 ↗
2. Surface chemistry of bioactive glass-ceramics10.1016/0022-3093(90)90199-V ↗
3. In vitro hydroxycarbonate apatite mineralization of CaO–SiO2 sol-gel glasses with a three-dimensionally ordered macroporous structure10.1021/cm000895e ↗
4. Effect of the substitution of M2O3 (M=La, Y, In, Ga, Al) for CaO on the bioactivity of 2.5CaO.2SiO2 glass10.1016/S0142-9612(01)00173-9 ↗
5. Biosilicate — A multipurpose, highly bioactive glass-ceramic. In vitro, in vivo and clinical trials10.1016/j.jnoncrysol.2015.03.022 ↗
6. Surface modifications of a glass and a glass-ceramic of the MgO-3CaO.P2O5-SiO2 system in a simulated body fluid10.1016/0142-9612(95)94146-C ↗
7. Bioactive glass for large bone repair10.1002/adhm.201500447 ↗
8. Bioactive glass particulate material as a filler for bone lesions10.1111/j.1365-2842.1991.tb01689.x ↗
9. Effect of copper-doped silicate 13-93 bioactive glass scaffolds on the response of MC3T3-E1 cells in vitro and on bone regeneration and angiogenesis in rat calvarial defects in vivo10.1016/j.msec.2016.05.073 ↗
10. Physico-chemical and in vitro cellular properties of different calcium phosphate-bioactive glass composite chitosan-collagen (CaP@ChiCol) for bone scaffolds10.1002/jbm.b.33652 ↗
11. Bioactive glass–ceramic coated titanium implants prepared by electrophoretic deposition10.1016/j.msec.2012.06.013 ↗
12. In vivo evaluation of bioactive glass-based coatings on dental implants in a dog implantation model
13. Injectable bioactive glass/biodegradable polymer composite for bone and cartilage reconstruction: concept and experimental outcome with thermoplastic composites of poly(ε-caprolactone-co-D,L-lactide) and bioactive glass S53P410.1023/B:JMSM.0000046401.50406.9b ↗
14. Highly bioactive P2O5-Na2O-CaO-SiO2 glass-ceramics10.1016/S0022-3093(01)00822-5 ↗
15. Phosphate glasses for tissue engineering (Part 1)10.1016/S0142-9612(03)00546-5 ↗
16. Bioactive functional materials: a perspective on phosphate-based glasses10.1039/B810675D ↗
17. Transformation of borate glasses into biologically useful materials
18. Reaction of sodium calcium borate glasses to form hydroxyapatite10.1007/s10856-007-3053-2 ↗
19. Compositional dependence on the in vitro bioactivity of invert or conventional bioglasses in the Si–Ca–Na–P system10.1002/jbm.a.31228 ↗
20. Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. II. In vitro and in vivo biological evaluation10.1002/jbm.a.32823 ↗
21. Bioactive glass in tissue engineering10.1016/j.actbio.2011.03.016 ↗
22. In vitro study of manganese-doped bioactive glasses for bone regeneration10.1016/j.msec.2014.01.045 ↗
23. Effects of TiO2-containing phosphate glasses on solubility and in vitro biocompatibility10.1002/jbm.a.33186 ↗
24. The effect of composition on ion release from Ca-Sr-Na-Zn-Si glass bone grafts10.1007/s10856-009-3789-y ↗
25. In vitro bioactive characteristics of borate-based glasses with controllable degradation behavior10.1111/j.1551-2916.2006.01358.x ↗
26. Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions10.1007/s10856-006-9220-z ↗
27. The synergistic effects of fibroblast growth factor-2 and mineral trioxide aggregate on an osteogenic accelerator in vitro10.1111/iej.12227 ↗
28. The effects of calcium silicate cement/fibroblast growth factor-2 composite on osteogenesis accelerator in human dental pulp cells10.1016/j.jds.2013.12.003 ↗
29. Physical stabilization of the beta gamma transformation in dicalcium silicate10.1111/j.1151-2916.1992.tb04234.x ↗
30. Performance of dicalcium silicate coatings in hot-corrosive environment10.1016/S0257-8972(01)01381-0 ↗
31. Reaction sintering of zircon–dolomite mixtures10.1016/S0955-2219(00)00212-0 ↗
32. Preparation and characterization of novel bioactive dicalcium silicate ceramics10.1016/j.jeurceramsoc.2004.05.029 ↗
33. Early apatite deposition and osteoblast growth on plasma-sprayed dicalcium silicate coating10.1002/jbm.a.30273 ↗
34. Study on in vitro bioactivity and cytotoxicity of gamma-Ca2SiO4 ceramic
35. Bioactive calcium silicate ceramics and coatings10.1016/j.biopha.2008.07.051 ↗
36. Mechanism of apatite formation on wollastonite coatings in simulated body fluids10.1016/j.biomaterials.2003.08.024 ↗
37. The effect of bioactive glasses on bone narrow stromal cells differentiation10.1016/j.biomaterials.2004.09.059 ↗
38. A novel injectable calcium phosphate cement-bioactive glass composite for bone regeneration
39. Effect of bioglass 45S5 addition on properties, microstructure and cellular response of tetracalcium phosphate/monetite cements10.1016/j.matchar.2017.02.013 ↗
40. Lea · 2004
41. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W10.1002/jbm.820240607 ↗
42. Characterization of the mineral trioxide aggregate–resin modified glass ionomer cement interface in different setting conditions10.1016/j.joen.2012.04.013 ↗
43. ASTM Designation: C373-88 · 1999
44. Rapid colorimetric assays for cellular growth and survival: application to proliferation and cytotoxicity assays10.1016/0022-1759(83)90303-4 ↗
45. Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay10.1111/j.2042-7158.1997.tb06055.x ↗
46. Screening of natural products for Therapeutic activity against solid tumors
47. Basic oxygen furnace (BOF) slag cooling: laboratory characteristics and prediction calculations10.1016/j.minpro.2013.05.002 ↗
48. The synergistic effects of Chinese herb and injectable calcium silicate/beta-tricalcium phosphate composite on an osteogenic accelerator in vitro10.1007/s10856-015-5484-5 ↗
49. Production and characterization of new calcium phosphate bone cements in the CaHPOv4-α-Ca3(PO4)2 system: pH, workability and setting times10.1023/A:1008958112257 ↗
50. Osteogenesis and angiogenesis properties of dental pulp cell on novel injectable tricalcium phosphate cement by silica doped10.1016/j.msec.2014.05.038 ↗
51. Novel bioactive composite bone cements based cement system10.1016/j.actbio.2008.10.006 ↗
52. Silicon substitution in the calcium phosphate bioceramics10.1016/j.biomaterials.2007.05.003 ↗
53. Mechanical characterization of brushite and hydroxyapatite cements10.1016/S0142-9612(01)00041-2 ↗
54. Porous surface modified bioactive bone cement for enhanced bone bonding
55. Enhanced osteoblastic activity and bone regeneration using surface-modified porous bioactive glass scaffolds10.1002/jbm.a.32773 ↗
56. Synthesis, characterization and in vitro bioactivity of sol-gel-derived SiO2-CaO-P2O5-MgO bioglass
57. Taylor · 1990
58. Physiochemical characterizations of hydroxyapatite extracted from bovine bones by three different methods: extraction of biologically desirable HAp10.1016/j.msec.2008.03.003 ↗
59. Preparation and characterization of wollastonite/titanium oxide nanofiber bioceramic composite as a future implant material10.1016/j.ceramint.2016.02.060 ↗
60. Enhancing the biological activity of vaterite-containing β-dicalcium silicate cement by silane coupling agent for biomaterials10.1016/j.msec.2018.06.003 ↗
61. Potential formation of hydroxyapatite in total blood and dicalcium silicate elaborated from shell and glass powders10.1016/j.matlet.2016.07.153 ↗
62. Synthesis of nanocrytalline fluorinated hydroxyapatite by microwave processing and its in vitro dissolution study10.1007/s12034-006-0012-3 ↗
63. Synergistically reinforcement of a self-setting calcium phosphate cement with bioactive glass fibers10.1016/j.ceramint.2010.11.002 ↗
64. Effects of mineral trioxide aggregate on human dental pulp cells after pulp-capping procedures10.1016/j.joen.2010.02.013 ↗
65. A comparative study of the effects of three root-end filling materials on proliferation and adherence of human periodontal ligament fibroblasts10.1016/j.joen.2011.03.011 ↗